Quaker Wealth Management
CRL icon

Quaker Wealth Management’s Charles River Laboratories CRL Stock Holding History

Quaker Wealth Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$886 Hold
3
– – ﹤0.01% 598
2026
Q2 		$681 Hold
3
– – ﹤0.01% 672
2026
Q1 		$518 Hold
3
– – ﹤0.01% 692
2025
Q4 		$599 Hold
3
– – ﹤0.01% 654
2025
Q3 		$470 Hold
3
– – ﹤0.01% 620
2025
Q2 		$456 Buy
+3
New +$400 ﹤0.01% 636

Other funds holding CRL

Cooke & Bieler
Cooke & Bieler Philadelphia, Pennsylvania $6.36B AUM 0.55% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Confluence Investment Management
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
Lawson Kroeker Investment Management
Lawson Kroeker Investment Management Omaha, Nebraska $360M AUM 21.88% 1-Year Est. Return
Midwest Trust
Midwest Trust Overland Park, Kansas $8.99B AUM 21.14% 1-Year Est. Return
Sendero Wealth Management
Sendero Wealth Management San Antonio, Texas $1B AUM 21.35% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
PensionDanmark
PensionDanmark Copenhagen O, Denmark $12.3B AUM 33.99% 1-Year Est. Return

Quaker Wealth Management's CRL Position: Q3 2026 in Review

Quaker Wealth Management held its Charles River Laboratories (CRL) position steady in Q3 2026 at 3 shares worth $886. The position accounts for ﹤0.01% of the portfolio, ranked #598.

Quaker Wealth Management first reported a position in CRL in Q2 2025 and has held it in 6 quarters since. 97 funds tracked by Wall St. Rank hold CRL as of Q3 2026.

  • Quaker Wealth Management held 3 shares of Charles River Laboratories worth $886 as of Q3 2026.
  • Quaker Wealth Management left its Charles River Laboratories share count unchanged in Q3 2026.
  • Charles River Laboratories made up ﹤0.01% of Quaker Wealth Management's portfolio in Q3 2026, its #598 holding.
  • Quaker Wealth Management first reported a position in Charles River Laboratories in Q2 2025 and has held it in 6 quarters since.
  • 97 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.

Based on Quaker Wealth Management's 13F filing for Q3 2026, filed 22 Oct 2026.